StockData

AdaptHealth vs Viemed Healthcare

AHCO and VMD side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AHCO and VMD compare

AdaptHealth is the larger company, worth 3.0 times as much as Viemed Healthcare ($1.0B against $345M).

Viemed Healthcare grew revenue faster over the last twelve months (25.2% versus 4.2% for AdaptHealth).

Viemed Healthcare keeps more of each dollar of sales as profit, with a net margin of 4.8% compared with −7.1% at AdaptHealth.

Viemed Healthcare scores higher on the StockData Score (17 against 6 for AdaptHealth), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAHCOVMD
Size and price
Market cap$1.0B$345M
Share price$7.53$9.07
Change, 1 year−18.1%41.9%
Change, 5 years−65.1%73.4%
Beta (5Y)−1.46−0.27
Employees11K1,382
StockData Score
Total score617 (better)
Valuation score34 (better)
Growth score05 (better)
Performance score03 (better)
Health score35 (better)
Dividend score00
Valuation
P/E–25.2×
P/S0.3× (better)1.1×
P/B0.7× (better)2.4×
EV/EBITDA10.5×8.9× (better)
P/FCF10.5× (better)11.8×
PEG–0.78
FCF yield9.5% (better)8.5%
Fair value$13.48$10.82
Margin of safety44.1% (better)16.2%
Growth
Revenue growth (TTM)4.2%25.2% (better)
Revenue growth, 5Y average25.2% (better)15.5%
Net income growth (TTM)−383%3.7% (better)
EPS growth (TTM)−419%5.9% (better)
EPS growth, 5Y average–−13.9%
Profitability
Gross margin17.0%57.5% (better)
Operating margin−4.5%7.5% (better)
Net margin−7.1%4.8% (better)
FCF margin3.0%9.7% (better)
Return on equity−15.4%10.2% (better)
Return on invested capital−3.4%12.2% (better)
Financial health
Debt / equity1.370.05 (better)
Net debt / EBITDA6.79 (better)−0.09
Current ratio1.121.13 (better)
Altman Z-score0.616.18 (better)
Piotroski F-score45 (better)
Dividends and buybacks
Buyback yield–5.3%
Shareholder yield0.00%5.3% (better)
Ownership
Held by institutions104%71.3%
Held by insiders14.7%15.4%
Insider net buying, 12 months$49.1M (better)−$1.6M
Short interest, % of float9.4%4.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.